Huntington's disease: from pathology and genetics to potential therapies
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Huntington's disease (HD) is a devastating autosomal dominant neurodegenerative disease caused by a CAG trinucleotide repeat expansion encoding an abnormally long polyglutamine tract in the huntingtin protein. Much has been learnt since the mutation was identified in 1993. We review the functions of wild-type huntingtin. Mutant huntingtin may cause toxicity via a range of different mechanisms. The primary consequence of the mutation is to confer a toxic gain of function on the mutant protein and this may be modified by certain normal activities that are impaired by the mutation. It is likely that the toxicity of mutant huntingtin is revealed after a series of cleavage events leading to the production of N-terminal huntingtin fragment(s) containing the expanded polyglutamine tract. Although aggregation of the mutant protein is a hallmark of the disease, the role of aggregation is complex and the arguments for protective roles of inclusions are discussed. Mutant huntingtin may mediate some of its toxicity in the nucleus by perturbing specific transcriptional pathways. HD may also inhibit mitochondrial function and proteasome activity. Importantly, not all of the effects of mutant huntingtin may be cell-autonomous, and it is possible that abnormalities in neighbouring neurons and glia may also have an impact on connected cells. It is likely that there is still much to learn about mutant huntingtin toxicity, and important insights have already come and may still come from chemical and genetic screens. Importantly, basic biological studies in HD have led to numerous potential therapeutic strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The number of these repeats determines both the time of onset of observable disease (more repeats meaning earlier onset) (Perutz and Windle 2001; Ross 1995; Walters and Murphy 2009), accounting for 70% of the variance (Imarisio et al. 2008), and the disease severity, implying that it is indeed the polyglutamines themselves that are the chief culprits.”
Citations
The citation lists are queued
They are fetched later and appear here then.
References 323 · Cited by 409
Research works printed but not linked: 8
- Huntington, 1872, On Chorea, 320
- Meynert, 1877, Discussion to Fritsch, Psychiatry, 4, 47
- Jelgersma, 1907, Die anatomischen Veranderungen bei. Paralysis agitans und chronischer Chorea, Verh. Ges. Dtsch. Naturforsch. Aerzte, 2, 383
- Tabrizi, 1999, Biochemical abnormalities and excitotoxicity in Huntington's disease brain, Ann. Neurol., 45, 25, 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E · doi:10.1002/1531-8249(199901)45:1<25::aid-art6>3.0.co;2-e
- Li, 2006, Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein, J. Biol. Chem., 281, 15916, 10.1074/jbc.M511007200 · DOI
- Kuppenbender, 2000, Expression of NMDA receptor subunit mRNAs in neurochemically identified projection and interneurons in the human striatum, J. Comp. Neurol., 419, 407, 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I · DOI · Paper page
- Faber, 1998, Huntingtin interacts with a family of WW domain proteins, Hum. Mol. Genet., 7, 1463, 10.1093/hmg/7.9.1463 · DOI · Paper page
- Kaltenbach, 2007, Huntingtin interacting proteins are genetic modifiers of neurodegeneration, PLoS Genet., 3, e82, 10.1371/journal.pgen.0030082 · DOI · Paper page
Metadata
- Authors
- Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Corresponding author
- Imarisio, Sara
- Carmichael, Jenny
- Korolchuk, Viktor
- Saiki, Shinji
- Rose, Claudia
- Krishna, Gauri
- Ttofi, Evangelia
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2008-05-14
- Volume
- 412
- Issue
- 2
- Pages
- 191-209
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W2130196517
- Cited by
- 409
- References
- 323
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 9 · 2021: 14 · 2020: 11 · 2019: 20 · 2018: 7 · 2017: 23 · 2016: 21 · 2015: 31 · 2014: 26 · 2013: 36 · 2012: 38
- FWCI
- 3.82
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Biochemical Journal (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (064354)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Keywords
- Huntington's disease, huntingtin, CAG repeat expansion, polyglutamine, gain-of-function toxicity, N-terminal huntingtin fragments, protein aggregation, intranuclear inclusions, transcriptional pathways, mitochondrial dysfunction, proteasome, glial interactions, treatment options, neurodegeneration
- MeSH terms
- Huntingtin Protein, Animals, Humans, Huntington Disease, Mitochondria, Models, Molecular, Mutation, Nerve Tissue Proteins, Nuclear Proteins, Transcription, Genetic, Reactive Oxygen Species, Protein Structure, Tertiary, Trinucleotide Repeat Expansion, Ubiquitin, Proteasome Endopeptidase Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Huntington's disease: from pathology and genetics to potential therapies. https://app.cochat.ai/papers/10.1042/bj20071619
- The paper
- Imarisio, S., Carmichael, J., Korolchuk, V., Chen, C.-W., Saiki, S., Rose, C., Krishna, G., Davies, J. E., Ttofi, E., Underwood, B. R., & Rubinsztein, D. C. (2008). Huntington's disease: from pathology and genetics to potential therapies. Biochemical Journal. https://doi.org/10.1042/bj20071619
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.